Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Eosinophilia Treatment and Management

Diagnostic Approach

  • The Journal of Infection recommends evaluating for common causes of eosinophilia, including parasitic infections, especially in those with travel history 1, 2
  • Stool microscopy and serology for specific helminth infections should be performed based on travel history 2, 3
  • For patients with gastrointestinal symptoms, consider endoscopy with multiple biopsies to evaluate for eosinophilic esophagitis 2
  • Patients with persistent eosinophilia ≥ 1.5 × 10⁹/L for more than 3 months without evidence of organ damage should be referred to a hematologist 1

Treatment Algorithm

  • For asymptomatic eosinophilia in patients aged > 24 months, the Journal of Infection recommends albendazole 400 mg single dose plus ivermectin 200 μg/kg single dose 1
  • For strongyloidiasis, ivermectin 200 μg/kg daily for 2 days is recommended 3
  • For schistosomiasis, praziquantel 40 mg/kg in two divided doses for 1 day is recommended 3
  • For onchocerciasis, diethylcarbamazine is recommended, but specialist advice should be sought due to potential adverse reactions 4

Eosinophilic Esophagitis Treatment

  • Proton pump inhibitor therapy twice daily for 8-12 weeks is recommended 3
  • Topical steroids can induce histological and clinical remission 3
  • A two-food elimination diet (milk +/- wheat or egg) for 8-12 weeks with dietitian support is recommended 2, 3

Management of Complications

  • For eosinophilic meningitis, corticosteroids plus albendazole are recommended 5
  • For neuroschistosomiasis, praziquantel 40 mg/kg twice daily for 5 days plus dexamethasone 4 mg four times daily is recommended 5
  • For toxocariasis with neurological involvement, corticosteroids plus albendazole are recommended 5
  • Any patient presenting with evidence of end-organ damage needs urgent medical assessment and consideration of emergency treatment 1

Monitoring Response

  • Follow-up eosinophil counts should be obtained after treatment to assess response 2
  • For eosinophilic esophagitis, histological remission is defined as <15 eosinophils per 0.3 mm² in tissue biopsies 2
  • For persistent eosinophilia despite treatment, consider referral to a hematologist for further investigation 1

Important Considerations

  • Persistent eosinophilia of any degree can cause significant end-organ damage, particularly affecting the heart, lungs, and central nervous system 1
  • Many people with helminth infection do not have eosinophilia, so testing for eosinophilia alone is not an adequate screening strategy for helminth infection 1
  • In some cases of persistent eosinophilia, no cause can be identified - termed idiopathic hypereosinophilia 1
  • For patients with refractory eosinophilia and/or significant concomitant atopic disease, consider joint management by appropriate specialists 2